Downregulation of MT1G, MT1X, and MT2A and upregulation of MT1F and MTF1 have been reported in AML cells,[56] suggesting a reduced capacity of AML cells to tolerate zinc fluctuations. The gene discussed is MT2A; the disease is acute myeloid leukemia.